Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sahin

Showing results (291-300 of 454) with videos related to

Pageof 46
Sort By:
Annals of Surgical Oncology|March 17, 2019
Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving SurgeryKo Un Park, Henry M Kuerer, Gaiane M Rauch, et al.
Human Pathology|July 28, 2019
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological featuresQingqing Ding, Hui Chen, Bora Lim, et al.
The Breast Journal|July 6, 2011
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancerMerih Guray Durak, Ana M Gonzalez-Angulo, Emer O Hanrahan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1994
Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomasA A Sahin, J Y Ro, R W Brown, et al.
Cancer Letters|September 2, 2019
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancerSumei Wang, Do-Youn Oh, Vasiliki Leventaki, et al.
Molecular Carcinogenesis|November 14, 2000
Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoproteinJ J Bao, B P Lee, L C Stephens, et al.
Journal of Cancer|July 2, 2019
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancerJing Ning, Tamer M Fouad, Heather Lin, et al.
BMC Complementary and Alternative Medicine|August 7, 2012
Knowledge and attitudes towards complementary and alternative medicine among medical students in TurkeyHulya Akan, Guldal Izbirak, Elif Ciğdem Kaspar, et al.
The American Journal of Pathology|May 17, 2016
Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerCansu Karakas, Anna Biernacka, Tuyen Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantationY S Kim, S N Konoplev, F Montemurro, et al.
Pageof 46

Showing results (291-300 of 454) with videos related to

Sort By:
Pageof 46
Annals of Surgical Oncology|March 17, 2019
Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving SurgeryKo Un Park, Henry M Kuerer, Gaiane M Rauch, et al.
Human Pathology|July 28, 2019
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological featuresQingqing Ding, Hui Chen, Bora Lim, et al.
The Breast Journal|July 6, 2011
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancerMerih Guray Durak, Ana M Gonzalez-Angulo, Emer O Hanrahan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1994
Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomasA A Sahin, J Y Ro, R W Brown, et al.
Cancer Letters|September 2, 2019
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancerSumei Wang, Do-Youn Oh, Vasiliki Leventaki, et al.
Molecular Carcinogenesis|November 14, 2000
Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoproteinJ J Bao, B P Lee, L C Stephens, et al.
Journal of Cancer|July 2, 2019
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancerJing Ning, Tamer M Fouad, Heather Lin, et al.
BMC Complementary and Alternative Medicine|August 7, 2012
Knowledge and attitudes towards complementary and alternative medicine among medical students in TurkeyHulya Akan, Guldal Izbirak, Elif Ciğdem Kaspar, et al.
The American Journal of Pathology|May 17, 2016
Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerCansu Karakas, Anna Biernacka, Tuyen Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantationY S Kim, S N Konoplev, F Montemurro, et al.
Pageof 46